Coherus BioSciences Inc.

12/18/2024 | Press release | Distributed by Public on 12/18/2024 07:30

Coherus to Present Final Phase 2 Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025